Gold Standard:Postoperative pathological diagnosis

4 trials

Sponsors

Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science Center, Fudan university Shanghai cancer center, Peking University First Hospital, Huashan Hospital, Fudan University

Conditions

Endometrial cancerHigh-Grade GliomasOvarian cancerUrothelial carcinoma

Early Phase 1

The clinical value of estrogen receptor ß5 expression in endometrial carcinogenesis

Active, not recruitingChiCTR2000035987

Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science CenterEndometrial cancer

Start: 2020-10-01Updated: 2020-08-31

Identification and clinical application of serum exocrine miRNA model in patients with CA125 negative high grade serous ovarian cancer

Active, not recruitingChiCTR2000037259

Fudan university Shanghai cancer centerOvarian cancer

Start: 2022-01-01Updated: 2020-10-13

Unknown Phase

Development, validation, and clinical application of a novel tumor marker based on urine DNA methylation for the non-invasive diagnosis of urinary for urothelial carcinoma

RecruitingChiCTR2200064162

Peking University First HospitalUrothelial carcinoma

Start: 2022-09-22Updated: 2023-04-17

Clinical Study of the CSF1R-Targeted Molecular Probe ¹¹C-CPPC for Imaging of High-Grade Gliomas

Active, not recruitingChiCTR2500102291

Huashan Hospital, Fudan UniversityHigh-Grade Gliomas

Start: 2025-05-16Updated: 2025-05-19